Healthcare -
Biotechnology - NASDAQ - US
$ 1.755
1.45 %
$ 267 M
Market Cap
-10.97
P/E
HRTX - INTEREST INCOME & EXPENSE
Interest Income & Expense HRTX - Heron Therapeutics, Inc.
3.87 M
LAST VALUE
26.69%
2 YEAR CAGR
7.68%
5 YEAR CAGR
16.69%
10 YEAR CAGR